» Articles » PMID: 14695931

Effects of Coenzyme Q10 in Huntington's Disease and Early Parkinson's Disease

Overview
Journal Biofactors
Publisher IOS Press
Specialty Biochemistry
Date 2003 Dec 30
PMID 14695931
Citations 32
Authors
Affiliations
Soon will be listed here.
Citing Articles

Innovative formulations for the ocular delivery of coenzyme Q10.

Signorini S, Pescina S, Ricci C, Del Favero E, Vivero-Lopez M, Alvarez-Lorenzo C Drug Deliv Transl Res. 2024; .

PMID: 39645537 DOI: 10.1007/s13346-024-01739-y.


Mitochondrial targeted antioxidants as potential therapy for huntington's disease.

Upadhayay S, Kumar P Pharmacol Rep. 2024; 76(4):693-713.

PMID: 38982016 DOI: 10.1007/s43440-024-00619-z.


Neuroprotective effects of coenzyme Q10 on neurological diseases: a review article.

Bagheri S, Haddadi R, Saki S, Kourosh-Arami M, Rashno M, Mojaver A Front Neurosci. 2023; 17:1188839.

PMID: 37424991 PMC: 10326389. DOI: 10.3389/fnins.2023.1188839.


Clinical, electrophysiological, and histomorphological effects of local coenzyme Q10 and vitamin E use in a rat model of peripheral nerve injury.

Olke H, Bicer O, Mirioglu A, Saker D, Ocal I, Ozkan C Acta Orthop Traumatol Turc. 2023; 57(1):23-29.

PMID: 36939361 PMC: 10152051. DOI: 10.5152/j.aott.2023.22121.


Antioxidant Therapeutic Strategies in Neurodegenerative Diseases.

Moren C, deSouza R, Giraldo D, Uff C Int J Mol Sci. 2022; 23(16).

PMID: 36012599 PMC: 9409201. DOI: 10.3390/ijms23169328.